Rockwell Medical (RMTI) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$69.4M

Revenue (quarter)

$17.8M

Revenue growth (year over year)

+10.63%

Gross profit (trailing twelve months)

$12.3M

Gross margin

17.71%

Net income (trailing twelve months)

−$5.1M

Net income (quarter)

−$1.2M

Net income growth (year over year)

+21.45%

Net margin

−7.33%

Return on equity

−15.53%

EPS (trailing twelve months)

−$1.32

Book value per share

$8.89

P/E (trailing twelve months)

—

Price to book

0.87

Debt to assets

37.93%

Payout ratio

—

Dividend yield

—

Company profile

Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.

• Is Rockwell Medical (RMTI) profitable?

  No. Rockwell Medical reported a net loss of $5.1M over the trailing twelve months.

• How much revenue does Rockwell Medical (RMTI) make?

  Rockwell Medical generated $69.4M in revenue over the trailing twelve months, up 10.63% year over year.

• How do I buy stock in Rockwell Medical (RMTI)?

  RMTI trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.